Strong Revenue and Earnings Growth
Diluted earnings per share grew by 42% year-over-year, and revenue increased by 9.6%, driven by broad-based volume growth and improved payer mix.
Positive Volume Trends
Same facility equivalent admissions increased by 2.4%, with surgical volumes and ER visits also seeing notable growth.
Improved Payer Mix
Same-facility total commercial equivalent admissions increased by 3.7%, with exchanges growing 8% and commercial admissions (excluding exchanges) growing 2.4%.
Enhanced Operational Efficiency
The company achieved better margins through disciplined operations, with improvements in labor, supplies, and a flat trend in contract labor expenses.
Increased Guidance for 2025
Guidance for full year revenue was updated to range between $75 billion and $76.5 billion, with adjusted EBITDA expected to range between $15.25 billion and $15.65 billion.